Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cue Biopharma (CUE) stocks
Learn how to easily invest in Cue Biopharma stocks.
Cue Biopharma is a biotechnology business based in the US. Cue Biopharma stocks (CUE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.01 – a decrease of 8.37% over the previous week. Cue Biopharma employs 51 staff and has a trailing 12-month revenue of around $432,227.
How to buy Cue Biopharma stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CUE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in Cue Biopharma?
- Has coronavirus impacted Cue Biopharma shares?
- Cue Biopharma shares summary
- Compare share dealing platforms
- Is Cue Biopharma stock a buy or sell?
- Cue Biopharma performance over time
- Cue Biopharma's financials
- How volatile are Cue Biopharma shares?
- Does Cue Biopharma pay a dividend?
- Other common questions
Cue Biopharma stock price (NASDAQ:CUE)Use our graph to track the performance of CUE stocks over time.
Cue Biopharma shares at a glance
|Latest market close||$3.72|
|52-week range||$2.18 - $5.12|
|50-day moving average||$3.89|
|200-day moving average||$3.27|
|Wall St. target price||$10.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.32|
Buy Cue Biopharma stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Cue Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cue Biopharma price performance over time
Historical closes compared with the close of $3.72 from 2023-06-07
|1 week (2023-06-01)||-8.37%|
|1 month (2023-05-08)||-24.24%|
|3 months (2023-03-08)||33.33%|
|6 months (2022-12-08)||14.81%|
|1 year (2022-06-08)||-1.59%|
|2 years (2021-06-07)||-72.71%|
|3 years (2020-06-08)||25.5|
|5 years (2018-06-08)||14.22|
Cue Biopharma financials
|Gross profit TTM||$1.2 million|
|Return on assets TTM||-38.17%|
|Return on equity TTM||-86.67%|
|Market capitalisation||$177.5 million|
TTM: trailing 12 months
Cue Biopharma share dividends
We're not expecting Cue Biopharma to pay a dividend over the next 12 months.
Cue Biopharma share price volatility
Over the last 12 months, Cue Biopharma's shares have ranged in value from as little as $2.18 up to $5.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cue Biopharma's is 2.0106. This would suggest that Cue Biopharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Cue Biopharma overview
Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company, develops injectable biologics to selectively engage and modulate tumor-specific T cells within the body to treat a range of cancers, chronic infectious diseases, and autoimmune diseases. Its lead drug product candidate is CUE-101, a fusion protein biologic designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate with Immuno-STAT targeting the KRAS G12V mutation, as well as cancer antigen MAGE-A4; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; and LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology.
Stocks similar to Cue Biopharma
Cue Biopharma in the news
Cue Biopharma to Host Investor Call
Cue Biopharma to Host Investor Call
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Bad credit loans in Edmonton, Alberta
From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
How to buy Arbitrum (ARB) in Canada
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
How to buy SSV Network (SSV) in Canada
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
How to buy USDD (USDD) in Canada
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
How to buy Blur (BLUR) in Canada
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
How to buy FLOKI Inu (FLOKI) in Canada
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
How to buy Aptos (APT) in Canada
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
How to buy EthereumPoW (ETHW) in Canada
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).